RecruitingNCT06339190

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Monash University
Principal Investigator
Prof. Amy Brodtmann, MBBS, FRACP, PhD, FANZAN
Monash University
Intervention
Venepuncture(diagnostic_test)
Enrollment
1000 enrolled
Eligibility
All sexes
Timeline
2021 – 2027

Study locations (2)

Collaborators

Eastern Health · University of Melbourne · Wake Forest University · Deakin University · The Florey Institute of Neuroscience and Mental Health · Invitae Corporation · Redenlab

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06339190 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials